Komori
Susmed (4263) · InitiativeRestated

Incentive Scheme for Enhancing Corporate Value over the Medium to Long Term Using a Stock Acquisition Rights Trust

First written in FY2022. 1 of 3 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2023.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2023-Q12022: 220222023: 12023
Same theme, other companies
Stock Acquisition Rights Trust and Gross Profit-Linked Talent IncentiveA theme 18 companies write about · 0 as a headwind · 18 as a tailwind

The whole theme swung hardest in 2023: 1 of 10 companies on the "Worse" side.

3 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 18 companies compared. The sentences above are computed from all 18.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「(i) If business revenue exceeds ¥1 billion: exercisable percentage 50% (ii) If business revenue exceeds ¥1.5 billion: exercisable percentage 100%」

    The Company continues to describe an incentive structure using a stock acquisition rights trust to allocate rights to employees and others based on business revenue.
  2. FY2023-Q1AdvancedAnnual report

    「For the purpose of maintaining and improving employee motivation and providing incentives to enhance corporate value over the medium to long term, based on a proposal by Ueno Taro (上野太郎), the Company's Representative Director and President, the Company entered into an agreement with コタエル信託 to establish a market-value-issued stock acquisition rights trust. The Company serves as the trust administrator and holder of the right to designate beneficiaries, and introduced an incentive plan using the trust by issuing these stock acquisition rights to コタエル信託.」

    The Company issued 8,000 Series 8 stock acquisition rights, representing 800,000 underlying shares, to a trust company in September 2022. The specific structure of the plan was described, under which 50% becomes exercisable when business revenue exceeds ¥1 billion and 100% when it exceeds ¥1.5 billion.
  3. FY2022First statedAnnual report

    「For the purpose of maintaining and improving employee motivation and providing incentives to enhance corporate value over the medium to long term, the Company entered into an agreement with コタエル信託 to establish a market-value-issued stock acquisition rights trust and」

    The Company introduced a stock acquisition rights trust as a medium- to long-term incentive for employees, with business revenue exceeding ¥1 billion and ¥1.5 billion serving as exercise conditions.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Susmed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Incentive Scheme for Enhancing Corporate Value over the Medium to Long Term Using a Stock Acquisition Rights Trust | SUSMED,Inc. (4263) | Komori